U.S. Markets open in 1 hr 35 mins
S&P Futures
2,465.00
-7.00 (-0.28%)Dow Futures
21,711.00
-32.00 (-0.15%)
| Previous Close | 32.89 |
| Open | 32.79 |
| Bid | 32.84 x 1500 |
| Ask | 33.30 x 300 |
| Day's Range | 32.69 - 33.00 |
| 52 Week Range | 29.83 - 37.39 |
| Volume | 75 |
| Avg. Volume | 20,302,725 |
| Market Cap | 196.94B |
| Beta | 1.07 |
| PE Ratio (TTM) | 27.78 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.87%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Market Realist•19 minutes ago
Behind Pfizer’s Legacy Established Products Performance in 2017
In 2016, Pfizer’s (PFE) Lipitor reported revenues of ~$1.8 billion, which represented a ~5% YoY (year-over-year) fall.
- The Wall Street Journal•6 hours ago
[$$] United Therapeutics in Settlement Talks With Justice Department
United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
- Motley Fool•11 hours ago
Mighty AstraZeneca Takes a Lickin' on Failed Mystic Trial
AstraZeneca's attempts to challenge competitors for dominance in treating non-small lung cancer were dashed today when data from a key trial came up short.
